🇺🇸 FDA
Pipeline program

ALT-801

ALT-801-101

Phase 1 small_molecule completed

Quick answer

ALT-801 for Obesity is a Phase 1 program (small_molecule) at Timmune Biotech with 1 ClinicalTrials.gov record(s).

Program details

Company
Timmune Biotech
Indication
Obesity
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials